Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Glycome Biopharma Limited manages a company patent portfolio within the Chemistry & Materials technology area. The portfolio contains 1 pending office action. This matter is assigned to 1 distinct examiner and 1 distinct art unit. This alignment indicates that the current prosecution is limited to a specific area of the Chemistry & Materials sector. Practitioners should note that the lack of multiple pending actions means there are no concurrent applications to provide broader context for the examiner's search patterns.
The busiest examiner for this portfolio is PEPITONE, MICHAEL F, who is responsible for 1 busiest examiner pending office action. Since the total pending office actions is 1, this examiner handles all active matters for the company. The prosecution results for the Chemistry & Materials filings are currently determined by this 1 examiner. For a practitioner, the prosecution path is defined by the requirements of this 1 examiner and the 1 distinct art unit involved. This concentration requires a strategy tailored to the specific feedback and prior art citations provided by PEPITONE, MICHAEL F, as no other examiners are currently reviewing the portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PEPITONE, MICHAEL F | 1 | 74.4% | +21.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18270626 | METHODS OF COATING POLYMERS AND REDUCTION IN PROTEIN AGGREGATION | PEPITONE, MICHAEL F | 30d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18270626 | METHODS OF COATING POLYMERS AND REDUCTION IN PROTEIN AGGREGATION | PEPITONE, MICHAEL F | 30d |
| Art Unit | Apps |
|---|---|
| 1767 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18270626 | METHODS OF COATING POLYMERS AND REDUCTION IN PROTEIN AGGREGATION | PEPITONE, MICHAEL F | 1767 | §102§103§112 | Non-Final OA | 30d | Pending | Jun 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial